NORADRENALINE OR DOPAMINE IN CARDIOGENIC SHOCK - A LITERATURE REVIEW
DOI:
https://doi.org/10.31435/ijitss.3(51).2026.4927Keywords:
Noradrenaline, Dopamine, Cardiogenic Shock, HypotensionAbstract
Introduction and purpose: Cardiogenic shock is a clinically specific cause of death that is hard to treat, and choosing the most effective medication remains a major clinical challenge. The aim of this study is to provide key information about this clinical condition and to compare the drugs most frequently used in the treatment of cardiogenic shock: noradrenaline and dopamine.
Materials and methods: A literature search was conducted using the medical database PubMed and Google Scholar. Articles were retrieved using the keywords: ,,Noradrenaline”, ,,Dopamine”, ,,Cardiogenic shock”, ,,Hypotension” in appropriate configuration.
Results: Four studies were found with relevant topics. One of these studies was excluded due to different vasopressors being compared in one of the trials considered in the meta-analysis. Finally, 3 scientific articles were systematically analyzed in our work.
Conclusions: According to the available medical literature, recommendations, and guidelines, the use of noradrenaline in patients with cardiogenic shock is usually the most appropriate choice. However, the choice of dopamine is also available but it has been linked with a higher risk of complications linked with cardiac arrhythmias.
References
van Diepen, S., Katz, J. N., Albert, N. M., et al. (2017). Contemporary management of cardiogenic shock: A scientific statement from the American heart association. Circulation, 136(16), e232–e268. https://doi.org/10.1161/CIR.0000000000000525
Kosaraju, A., Pendela, V. S., & Hai, O. (2025). Cardiogenic shock. In: StatPearls [Internet]; Treasure Island (FL): StatPearls Publishing, Jan–. Available online: https://www.ncbi.nlm.nih.gov/books/NBK482255/
Berg, D. D., Bohula, E. A., van Diepen, S., et al. (2019). Epidemiology of shock in contemporary cardiac intensive care units. Circ. Cardiovasc. Qual. Outcomes, 12(3), e005618. https://doi.org/10.1161/CIRCOUTCOMES.119.005618
Dziewierz, A. (2022). Postępowanie we wstrząsie kardiogennym – aktualne zalecenia. Kardiologia po Dyplomie, 21(3), 51–60. Available online: https://podyplomie.pl/kardiologia/37678,postepowanie-we-wstrzasie-kardiogennym-aktualne-zalecenia
Jankowski, M. (n.d.). Wstrząs kardiogenny. In: Interna – podręcznik Medycyna Praktyczna; Medycyna Praktyczna: Kraków; Available online: https://www.mp.pl/interna/chapter/B16.II.2.2.2/
Shaw, D. B., Hunsucker, S., Van Scoy, B., et al. (2021). Impact of early versus delayed renal replacement therapy initiation on outcomes in critically ill patients with acute kidney injury. J. Crit. Care, 65, 276–282. https://doi.org/10.1080/21556660.2021.1930548
De Backer, D., Biston, P., Devriendt, J., et al. (2010). Comparison of dopamine and norepinephrine in the treatment of shock. N. Engl. J. Med., 362(9), 779–789. https://doi.org/10.1056/NEJMoa0907118
Hosoya, Y., Yamamoto, M., Hanada, H., et al. (2025). Comparative efficacy of noradrenaline vs. other vasopressors on outcomes in patients with cardiogenic shock ― a systematic review and Meta‑Analysis. Circrep, 7(12), 1154–1161. https://doi.org/10.1253/circrep.cr-25-0188
Na, S. J., Yang, J. H., Ko, R.‑E., et al. (2022). Dopamine versus norepinephrine as the first‑line vasopressor in the treatment of cardiogenic shock. PLoS ONE, 17(11), e0277087. https://doi.org/10.1371/journal.pone.0277087
Rui, Q., Jiang, Y., Chen, M., et al. (2017). Dopamine versus norepinephrine in the treatment of cardiogenic shock: A PRISMA‑compliant meta‑analysis. Medicine (Baltimore), 96(43), e8402. https://doi.org/10.1097/MD.0000000000008402
De Backer, D., Biston, P., Devriendt, J., et al. (2010). Comparison of dopamine and norepinephrine in the treatment of shock. N. Engl. J. Med., 362(9), 779–789. https://doi.org/10.1056/NEJMoa0907118
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Antoni Liebert, Katarzyna Mazurek, Anna Dominiczak, Marta Brzęcka, Stanisław Rogiński, Karol Krupiniewicz, Marek Wojciechowicz, Miłosz Rogiński, Mariusz Suchcicki, Łukasz Chojnowski
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
